IL-17 inhibits chondrogenic differentiation of human mesenchymal stem cells

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Kondo, Masahiro ^a,b   Yamaoka, Kunihiro ^a   Sonomoto, Koshiro ^a   Fukuyo, Shunsuke ^a   Oshita, Koichi ^b   Okada, Yosuke ^a   Tanaka, Yoshiya ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^b MITSUBISHI TANABE PHARMA CORPORATION   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE; INTERLEUKIN 17; INTERLEUKIN 1BETA; SMAD2 PROTEIN; TRANSCRIPTION FACTOR SOX9; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; CARTILAGE MATRIX; CELL AGGREGATION; CELL DIFFERENTIATION; CELL GROWTH; CELL NUCLEUS; CHONDROGENESIS; CONTROLLED STUDY; CYTOPLASM; CYTOTOXICITY; ENZYME ACTIVITY; GROWTH INHIBITION; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS;

CELL DIFFERENTIATION; CELLS, CULTURED; CHONDROGENESIS; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-17; MESENCHYMAL STROMAL CELLS; MICROSCOPY, FLUORESCENCE; PHOSPHORYLATION; SOX9 TRANSCRIPTION FACTOR;

EID: 84896704152     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0079463     Document Type: Article

References (49)

1. Alsalameh S, Amin R, Gemba T, Lotz M (2004) Identification of mesenchymal progenitor cells in normal and osteoarthritic human articular cartilage. Arthritis Rheum 50: 1522-1532. (Pubitemid 38608074)
2. Dowthwaite GP, Bishop JC, Redman SN, Khan IM, Rooney P, et al. (2004) The surface of articular cartilage contains a progenitor cell population. J Cell Sci 117: 889-897. (Pubitemid 38386946)
3. Pretzel D, Linss S, Rochler S, Endres M, Kaps C, et al. (2011) Relative percentage and zonal distribution of mesenchymal progenitor cells in human osteoarthritic and normal cartilage. Arthritis Res Ther 13: R64.
4. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, et al. (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284: 143-147. (Pubitemid 29282067)
5. Sonomoto K, Yamaoka K, Oshita K, Fukuyo S, Zhang X, et al. (2012) Interleukin-1β induces differentiation of human mesenchymal stem cells into osteoblasts via the Wnt-5a/receptor tyrosine kinase-like orphan receptor 2 pathway. Arthritis Rheum 64: 3355-3363.
6. Oshita K, Yamaoka K, Udagawa N, Fukuyo S, Sonomoto K, et al. (2011) Human mesenchymal stem cells inhibit osteoclastogenesis through osteoprotegerin production. Arthritis Rheum 63: 1658-1667.
7. Kayakabe M, Tsutsumi S, Watanabe H, Kato Y, Takagishi K (2006) Transplantation of autologous rabbit BM-derived mesenchymal stromal cells embedded in hyaluronic acid gel sponge into osteochondral defects of the knee. Cytotherapy 8: 343-353. (Pubitemid 44269673)
8. Luyten FP (2004) Mesenchymal stem cells in osteoarthritis. Curr Opin Rheumatol 16: 599-603.
9. Wehling N, Palmer GD, Pilapil C, Liu F, Wells JW, et al. (2009) Interleukin-1beta and tumor necrosis factor alpha inhibit chondrogenesis by human mesenchymal stem cells through NF-kappaB-dependent pathways. Arthritis Rheum 60: 801-812.
10. Klareskog L, van der Heijde D, de Jager JP, Gough A, Kalden J, et al. (2004) Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial. The Lancet 363: 675-681. (Pubitemid 38296553)
11. Choy E (2012) Understanding the dynamics: pathways involved in the pathogenesis of rheumatoid arthritis. Rheumatology 51: v3-v11.
12. Lubberts E, Koenders MI, Oppers-Walgreen B, van den Bersselaar L, Coenende Roo CJJ, et al. (2004) Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion. Arthritis Rheum 50: 650-659. (Pubitemid 38198849)
13. Lubberts E, Joosten LAB, Oppers B, van den Bersselaar L, Coenen-de Roo CJJ, et al. (2001) IL-1-independent role of IL-17 in synovial inflammation and joint destruction during collagen-induced arthritis. J Immunol 167: 1004-1013. (Pubitemid 32660858)
14. Nakae S, Nambu A, Sudo K, Iwakura Y (2003) Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice. J Immunol 171: 6173-6177. (Pubitemid 37467240)
15. Ziolkowska M, Koc A, Luszczykiewicz G, Ksiezopolska-Pietrzak K, Klimczak E, et al. (2000) High levels of IL-17 in rheumatoid arthritis patients: IL-15 triggers in vitro IL-17 production via cyclosporin A-sensitive mechanism. J Immunol 164: 2832-2838. (Pubitemid 30115519)
16. Kotake S, Udagawa N, Takahashi N, Matsuzaki K, Itoh K, et al. (1999) IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J Clin Invest 103: 1345-1352. (Pubitemid 29218305)
17. Hitchon CA, Alex P, Erdile LB, Frank MB, Dozmorov I, et al. (2004) A distinct multicytokine profile is associated with anti-cyclical citrullinated peptide antibodies in patients with early untreated inflammatory arthritis. J Rheumatol 31: 2336-2346. (Pubitemid 39603079)
18. Pène J, Chevalier S, Preisser L, Vénéreau E, Guilleux M-H, et al. (2008) Chronically inflamed human tissues are infiltrated by highly differentiated Th17 lymphocytes. J Immunol 180: 7423-7430.
19. Koshy PJ, Henderson N, Logan C, Life PF, Cawston TE, et al. (2002) Interleukin 17 induces cartilage collagen breakdown: novel synergistic effects in combination with proinflammatory cytokines. Ann Rheum Dis 61: 704-713. (Pubitemid 34787708)
20. Chabaud M, Garnero P, Dayer J-M, Guerne P-A, Fossiez F, et al. (2000) Contribution of interleukin 17 to synovium matrix destruction in rheumatoid arthritis. Cytokine 12: 1092-1099. (Pubitemid 30479493)
21. Chabaud M, Lubberts E, Joosten L, van den Berg W, Miossec P (2001) IL-17 derived from juxta-articular bone and synovium contributes to joint degradation in rheumatoid arthritis. Arthritis Res 3: 168-177. (Pubitemid 32303433)
22. Li TF, O'Keefe RJ, Chen D (2005) TGF-beta signaling in chondrocytes. Front Biosci 10: 681-688.
23. Akiyama H, Chaboissier MC, Martin JF, Schedl A, de Crombrugghe B (2002) The transcription factor Sox9 has essential roles in successive steps of the chondrocyte differentiation pathway and is required for expression of Sox5 and Sox6. Genes Dev 16: 2813-2828. (Pubitemid 35253149)
24. Bi W, Deng JM, Zhang Z, Behringer RR, de Crombrugghe B (1999) Sox9 is required for cartilage formation. Nat Genet 22: 85-89. (Pubitemid 29214811)
25. Foster JW, Dominguez-Steglich MA, Guioli S, Kwok C, Weller PA, et al. (1994) Campomelic dysplasia and autosomal sex reversal caused by mutations in an SRY-related gene. Nature 372: 525-530. (Pubitemid 24368528)
26. Huang W, Zhou X, Lefebvre V, de Crombrugghe B (2000) Phosphorylation of SOX9 by cyclic AMP-dependent protein kinase A enhances SOX9's ability to transactivate a Col2a1 chondrocyte-specific enhancer. Mol Cel Biol 20: 4149-4158. (Pubitemid 30314512)
27. Huang W, Chung U-i, Kronenberg HM, de Crombrugghe B (2001) The chondrogenic transcription factor Sox9 is a target of signaling by the parathyroid hormone-related peptide in the growth plate of endochondral bones. Proc Natl Acad Sci USA 98: 160-165. (Pubitemid 32095880)
28. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408. (Pubitemid 34164012)
29. Ren G, Zhang L, Zhao X, Xu G, Zhang Y, et al. (2008) Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. Cell Stem Cell 2: 141-150. (Pubitemid 351181031)
30. Ren G, Zhao X, Zhang L, Zhang J, L'Huillier A, et al. (2010) Inflammatory cytokine-induced intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in mesenchymal stem cells are critical for immunosuppression. J Immunol 184: 2321-2328.
31. Sitcheran R, Cogswell PC, Baldwin AS (2003) NF-k B mediates inhibition of mesenchymal cell differentiation through a posttranscriptional gene silencing mechanism. Genes Dev 17: 2368-2373. (Pubitemid 37214785)
32. Baugé C, Legendre F, Leclercq S, Elissalde JM, Pujol JP, et al. (2007) Interleukin-1b impairment of transforming growth factor b1 signaling by down-regulation of transforming growth factor b receptor type II and up-regulation of Smad7 in human articular chondrocytes. Arthritis Rheum 56: 3020-3032. (Pubitemid 47502749)
33. Roman-Blas JA, Stokes DG, Jimenez SA (2007) Modulation of TGF-β signaling by proinflammatory cytokines in articular chondrocytes. Osteoarthritis Cartilage 15: 1367-1377. (Pubitemid 350048557)
34. Baugé C, Attia J, Leclercq S, Pujol JP, Galéra P, et al. (2008) Interleukin-1β upregulation of Smad7 via NF-κB activation in human chondrocytes. Arthritis Rheum 58: 221-226.
35. Kawakami Y, Rodriguez-León J, Belmonte JCI (2006) The role of TGFßs and Sox9 during limb chondrogenesis. Curr Opin Cell Biol 18: 723-729. (Pubitemid 44692480)
36. Chikuda H, Kugimiya F, Hoshi K, Ikeda T, Ogasawara T, et al. (2004) Cyclic GMP-dependent protein kinase II is a molecular switch from proliferation to hypertrophic differentiation of chondrocytes. Genes Dev 18: 2418-2429. (Pubitemid 39304688)
37. Haudenschild DR, Chen J, Pang N, Lotz MK, D'Lima DD (2010) Rho kinase-dependent activation of SOX9 in chondrocytes. Arthritis Rheum 62: 191-200.
38. Kosher RA, Gay SW, Kamanitz JR, Kulyk WM, Rodgers BJ, et al. (1986) Cartilage proteoglycan core protein gene expression during limb cartilage differentiation. Dev Biol 118: 112-117. (Pubitemid 17179017)
39. Malemud CJ, Mills TM, Shuckett R, Papay RS (1986) Stimulation of sulfated-proteoglycan synthesis by forskolin in monolayer cultures. J Cell Physiol 129: 51-59. (Pubitemid 17178525)
40. Ham O, Song B-W, Lee S-Y, Choi E, Cha M-J, et al. (2012) The role of microRNA-23b in the differentiation of MSC into chondrocyte by targeting protein kinase A signaling. Biomaterials 33: 4500-4507.
41. Yoo JU, Barthel TS, Nishimura K, Solchaga L, Caplan AI, et al. (1998) The chondrogenic potential of human bone-marrow-derived mesenchymal progenitor cells. J Bone Joint Surg 80: 1745-1757. (Pubitemid 29013807)
42. Li X, Yuan F-L, Lu W-G, Zhao Y-q, Li C-w, et al. (2010) The role of interleukin-17 in mediating joint destruction in rheumatoid arthritis. Biochem Biophys Res Commun 397: 131-135.
43. Heldens GT, Blaney Davidson EN, Vitters EL, Schreurs BW, Piek E, et al. (2012) Catabolic factors and osteoarthritis-conditioned medium inhibit chondrogenesis of human mesenchymal stem cells. Tissue Eng Part A 18: 45-54.
44. Clark CA, Schwarz EM, Zhang X, Ziran NM, Drissi H, et al. (2005) Differential regulation of EP receptor isoforms during chondrogenesis and chondrocyte maturation. Biochem Biophys Res Commun 328: 764-776. (Pubitemid 40208315)
45. Simon TM, Jackson DW (2006) Articular Cartilage: Injury pathways and treatment options. Sports Med Arthros 14: 146-54.
46. Steinert A, Ghivizzani S, Rethwilm A, Tuan R, Evans C, et al. (2007) Major biological obstacles for persistent cell-based regeneration of articular cartilage. Arthritis Res Ther 9: 213.
47. Djouad F, Mrugala D, Noël D, Jorgensen C (2006) Engineered mesenchymal stem cells for cartilage repair. Regen Med 1: 529-537.
48. Abumaree M, Al Jumah M, Pace R, Kalionis B (2012) Immunosuppressive properties of mesenchymal stem cells. Stem Cell Rev 8: 375-392.
49. Jorgensen C, Noël D (2011) Mesenchymal stem cells in osteoarticular diseases. Regen Med 6: 44-51.